8-K: Allied Corp. Secures Five-Year Cannabis Supply Agreement with CanPoland

Allied Corp.'s subsidiary, Allied Colombia S.A.S., has entered into a five-year forward purchase agreement to supply medical-grade cannabis to CanPoland for distribution in Poland.

Summary

• Allied Corp., through its subsidiary Allied Colombia S.A.S., has signed a five-year forward purchase agreement with CanPoland Spolka Akcyjna and Blossom Genetics Lda.
• Under the agreement, Allied will supply THC and CBD medical-grade cannabis products, manufactured by Blossom Genetics Lda, to CanPoland for sale in Poland.
• The agreement includes exclusivity for the territory of Poland and specifies minimum order quantities (MOQs) for three cannabis strains: Duende, Gods Cookie, and Sundae Stallion.
• CanPoland will provide a rolling six-month forecast of its estimated demand, and the parties will hold quarterly meetings to agree on supply requirements.
• Purchase orders will be submitted by CanPoland and must be accepted in writing by both the manufacturer and producer.
• The processing time at the manufacturer's site is expected to be approximately 8-10 weeks after acceptance of the purchase order and raw product arrival.
• Pricing is based on the annual MOQs, and failure to meet these MOQs in any six-month period may result in either payment for the remaining MOQ or forfeiture of exclusivity.
• The agreement includes payment terms, late fees, and conditions for termination, including material breaches, insolvency, and loss of licenses.
• Delivery will be DAP (Buyer's Facility, Poland), with CanPoland responsible for customs clearance and import duties.
• The agreement is governed by the laws of England and Wales and includes a dispute resolution process.

Sentiment

Score: 8

Explanation: The agreement is a positive development for Allied Corp., securing a long-term supply contract in a growing market. The terms are generally favorable, with clear obligations and a dispute resolution process. The agreement is expected to have a positive impact on the company's revenue and market position.

Positives

• The agreement provides a stable, long-term revenue stream for Allied Corp. through a five-year commitment.
• The exclusivity clause for Poland gives Allied a strong foothold in the Polish market.
• The agreement includes minimum order quantities, ensuring a baseline level of sales.
• The agreement includes a clear process for purchase orders, delivery, and payment.
• The agreement includes a dispute resolution process, reducing the risk of protracted legal battles.

Negatives

• Failure to meet minimum order quantities (MOQs) by CanPoland could result in loss of exclusivity or payment for the remaining MOQ.
• The agreement includes a potential late fee of 5% per annum for payments not made within 5 days of the due date.
• CanPoland is responsible for all customs clearance procedures and import duties, which could add complexity and cost.
• The agreement allows for termination under various conditions, including material breaches and insolvency, which could disrupt the supply chain.
• The agreement is governed by the laws of England and Wales, which may be less familiar to the parties than their local laws.

Risks

• The agreement is subject to potential delays in processing times at the manufacturer's site, which could impact delivery schedules.
• Changes in Polish regulations or import policies could affect the agreement's viability.
• CanPoland's failure to meet MOQs could lead to financial penalties or loss of exclusivity.
• The agreement is subject to termination under various conditions, including material breaches and insolvency.
• The agreement is subject to force majeure events, which could disrupt the supply chain.

Future Outlook

The agreement provides a framework for a five-year supply relationship, with annual reviews of pricing and MOQs. The parties will participate in quarterly meetings to establish and agree to the supply requirements of the Buyer. The Buyer will provide a rolling 6 month forecast of the Buyers estimated demand of Manufacturer and Producer products for planning purposes only.

Management Comments

• There are no direct quotes from management in the document, but the agreement signifies a strategic move to expand into the European market.

Industry Context

This agreement reflects the growing trend of international trade in medical cannabis, with companies seeking to establish supply chains across different countries. The agreement is a significant step for Allied Corp. in expanding its global reach and capitalizing on the increasing demand for medical cannabis in Europe.

Comparison to Industry Standards

• The agreement is similar to other international cannabis supply agreements, which often include exclusivity clauses, minimum order quantities, and specific delivery terms.
• Companies like Aurora Cannabis and Tilray have also pursued similar international supply agreements to expand their market reach.
• The five-year term of the agreement is a relatively long-term commitment, which is common in the cannabis industry to ensure supply stability.
• The agreement's focus on EU GMP standards is consistent with the requirements for medical cannabis in Europe.
• The use of DAP (Delivered at Place) Incoterms is a standard practice in international trade.

Stakeholder Impact

• Shareholders will likely view this agreement positively as it secures a long-term revenue stream.
• Employees may benefit from increased job security and potential growth opportunities.
• Customers in Poland will have access to medical-grade cannabis products.
• Suppliers to Allied Corp. may see increased demand for their products.
• Creditors may view the agreement as a positive sign of the company's financial stability.

Next Steps

• CanPoland will submit purchase orders to the manufacturer.
• The manufacturer will process the cannabis products.
• The products will be delivered to CanPoland in Poland.
• The parties will participate in quarterly meetings to establish and agree to the supply requirements of the Buyer.
• The parties will review and agree on MOQs 3 months before the end of each 12 month anniversary of the agreement.
• The parties will conduct annual price reviews 3 months before the end of each contract year.

Key Dates

Keywords

cannabis, medical cannabis, forward purchase agreement, THC, CBD, Poland, CanPoland, Blossom Genetics, Allied Corp, supply agreement, exclusivity, minimum order quantity, GACP, EU GMP